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ABSTRACT 
Altered gene expression is a hallmark of neurodegenerative disorders such as Huntington’s 
disease. The causative agent of Huntington’s is a mutant, aggregation-prone fragment of huntingtin 
(htt) that aggregates in the cytosol and nuclei of neuronal cells. The severity and onset of 
Huntington’s is correlated with the length of a polyglutamine (Q) tract encoded in the N-terminus 
of htt. Little is known about the nuclear accumulation of polyQ expanded htt, how it interacts with 
chromatin, and dysregulates transcriptional activity. In this thesis, we investigate the effect of 
nuclear localized htt on reporter gene activation and demonstrate that the human SUMO-targeted 
ubiquitin ligase RNF4 reduces htt’s transcriptional activity in a tissue culture model of 
Huntington’s disease. Additionally, we tested the capacity of RNF4 truncations to modulate htt 
expression – RING and SIM deletions of RNF4 were found to have enhanced inhibitory function 
compared to full length RNF4, and these unexpected findings are discussed. In summary, our 
results provide novel insights into the nuclear functions of htt and suggest a model for the 
functional interaction with SUMO-targeted ubiquitin ligases.   
 
INTRODUCTION 
Huntington’s Disease 
Protein misfolding is a major factor of cellular stress and can result in protein aggregation 
and the disruption of vital cellular processes. Proteins misfold and aggregate due to proteotoxic 
stressors including mutations, environmental factors such as pH or oxidative damage, and 
senescence. Protein aggregation creates a host of problems and has been implicated in the 
pathology of neurodegenerative disorders such as Alzheimer’s, Lou Gehrig’s, Parkinson’s and 
Huntington’s disease. In the case of Huntington’s disease, a region of the huntingtin gene on 
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chromosome IV that encodes a series of glutamine (Q) repeats is expanded, resulting in a harmful, 
aggregation-prone polyQ tract in the expressed protein. While this gene is vital to cells during 
development and 17-28 Q repeats are normally present in the huntingtin protein (htt), patients with 
Huntington’s often exhibit upward of 36 Q residues in htt. Due to the high GC content and 
polymerase slippage, polyQ-encoding tracts that include 29-35 Q are thought to be genomically 
unstable and prone to changes in length during replication; the overwhelming majority of changes 
to these unstable glutamine tracts result in elongation of the polyQ tract and propagation of 
Huntington’s disease [Roos 2010]. Patients with trinucleotide repeat disorders including 
Huntington’s experience genetic anticipation, as successive generations have earlier onset and 
severity of Huntington’s due to a gradual generational lengthening polyQ region [Wells 1996]. 
The length of the polyQ tract is inversely correlated to age of onset of Huntington’s disease, with 
juvenile cases of Huntington’s often presenting with polyQ tracts exceeding 55Q and mild, late-
onset cases containing between than 30 and 40Q [Roos 2010]. 
Huntington’s disease is inherited in an autosomal dominant manner, as the aggregation-
prone form of htt has a dominant negative effect [Hooper 2010]. Homozygosity of disease-causing 
alleles is very rare due to the infrequent mating of heterozygotes, but there is evidence that 
homozygotes do not present significantly different symptoms, severity, or clinical course of 
Huntington’s disease [Wexler 1987]. While there are no current treatments for the root cause of 
the disease, patients are treated for their resulting symptoms. Huntington’s appears as deterioration 
of motor function, neurological processing, and psychiatric state [Roos 2010]. Impaired motor 
control presents as chorea (involuntary movement) and is often treated with tetrabenazine- a 
monoamine transport inhibitor or antipsychotic drugs to treat neuropathological symptoms 
[Paleacu 2007]. Dementia, impaired spatial reasoning, and regressing language processing also 
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result from the basal ganglia neural atrophy seen in Huntington’s disease, and is treated through 
psychotherapy and speech therapy. Finally, multiple psychiatric changes including depression, 
anxiety, apathy, irritation, and psychosis are frequently seen in Huntington’s patients and treated 
with antidepressants, antipsychotic drugs, lifestyle changes, and counseling to counteract their 
elevated suicide risk [Mayo Clinic 2017]. While these treatments may improve quality of life, none 
of them affect the abnormal folding of huntingtin and its associated functions. 
MRI scans and post-mortem analysis of Huntington’s patients reveal that there is neuronal 
degeneration in the striatum of the basal ganglia, cerebral cortex, thalamus, and cerebellum 
[Kassubek 2004]. The atrophy in the basal ganglia is the most conserved between Huntington’s 
patients, and readily accounts for impaired motor function and cognition. Mutant htt is thought to 
induce cell death through autophagy and possibly apoptosis, although the exact mechanisms 
remain unknown [Hooper 2010].  
When the mutant, expanded version of htt is produced, it disrupts many cellular processes 
through its polyglutamine region. Htt normally encodes a 350 kDa protein that contains a 
glutamine-rich N terminus followed by a polyproline rich region, which is thought to stabilize 
protein conformation and make htt soluble [Figure 1]. The N terminus also contains 10 HEAT 
repeats presumed to be involved in protein interactions and vesicle trafficking [Hooper 2010] 
[Bano 2011]. Htt contains sites for N-terminal cleavage by caspases (cellular proteases), 
phosphorylation, and SUMOylation. The polyQ tract is flanked by alpha helices and polyproline 
helices on its N and C terminal sides, respectively [Kim 2009]. Between these helices, the polyQ 
region adopts multiple conformations, including helices, random coils, and extended loops. When 
the polyQ region is expanded in Huntington’s, the random coil extends and htt inappropriately 
interacts with other proteins, especially those with polyQ tracts, to form aggregates [Kim 2009].  
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Figure 1.  Representation of Huntingtin (htt) and depiction of functional domains. The 
glutamine repeats located on the N-terminal portion of htt are extended to upwards of 36Q and 
lead to the neuronal inclusion bodies and atrophy seen in Huntington’s patients.  
 
The native function of htt is not entirely clear, though it has been established that htt is an 
essential protein in neurogenesis, apoptosis, and vesicle trafficking [Hooper 2010]. Htt is found 
primarily in the cytoplasm, but can localize to the mitochondria, golgi apparatus, endoplasmic 
reticulum, and importantly the nucleus [Trottier 1995]. Significantly, htt has also been shown to 
interact with some transcription factors and other regulatory proteins with polyQ tracts [Atanesyan 
2012] [Perutz 1994]. Current research has identified significant changes in the transcriptional 
profile of early-stage Huntington’s, notably impairing mitochondrial function and developmental 
processes [Hagen 2017]. While the polyQ region may serve as a basis for transcription factor 
interaction, it is also the underlying cause of the neuronal cell aggregates that are characteristic of 
Huntington’s disease.  
Protein Aggregation in Huntington’s Disease 
 As mutant htt aggregates accumulate, they have the propensity to form cellular inclusion 
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bodies. Inclusion bodies are formed when N-terminal fragments of htt interact with each other and 
recruit other proteins into the growing complex. Glutamine forms hydrogen bonds with other polar 
residues, and the extended random loop allows for non-specific interactions. PolyQ extended htt 
can be cleaved by cellular proteases and the fragments of htt appear to be more toxic than the full 
length version, as cleavage stabilizes the polyQ region and removes the nuclear export signal [Liou 
2011]. Inclusion bodies in the cytoplasm disrupt neuronal cell shape and axon function while 
inclusion bodies in the nucleus are far less understood, but are thought to inappropriately interact 
with regulatory factors to alter transcription. 
Small htt aggregates may not be a problem in and of themselves, but when they recruit 
essential regulatory factors or cell maintenance proteins into the complex, cell homeostasis is 
disrupted. For example, mutant htt has been shown to entangle CREB-binding protein (CBP- a 
protein involved in memory) through glutamine interaction, which eventually leads to neuronal 
death [Cong 2005]. Interestingly, when the 18Q tract of CBP was removed, the protein was not 
recruited to the aggregate and neuronal cell death was reduced. Many of the established targets of 
mutant htt interaction contain polyglutamine regions, suggesting that binding occurs in a 
glutamine-dependent manner. Aggregates are thought to be a result of the polyQ tract forming new 
interactions, but other regions of htt also modulate aggregate formation. The proline-rich region 
that immediately follows the polyQ region modulates both the rate and mode of aggregation, as 
deleting this region changes the morphology of aggregates while duplicating it decreases the rate 
of htt aggregation in yeast, a model system used to study hunting aggregates [Arrasate 2012].  
Post-Translational Modifications in Cellular Stress 
In general, misfolded and aggregating proteins can be targeted for destruction via the 
ubiquitin-proteasome system (UPS). The covalent attachment of ubiquitin (Ub), a protein around 
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8.5 kDa, to a target lysine (K) fundamentally alters the target protein’s role in the cell. Mono-
ubiquitination is thought to serve as a signal, for example leading to endocytosis, membrane 
trafficking, and altered histone conformation [Sadowski 2010]. Ubiquitin contains lysine at 
residues 6, 11, 27, 29, 33, 48, and 63, allowing for the formation of poly-ubiquitin chains 
[Suryadinata 2013]. The location of the poly-ubiquitin attachment results in differential cellular 
targeting and controls whether the protein is to be degraded. For example, DNA repair mechanisms 
rely on poly-ubiquitination of proteins through Ub K63 linked chains while the UPS system relies 
on poly-ubiquitination of targets through attachment of Ub K48 linked chains. The process of 
attaching ubiquitin to a target protein involves three classes of enzymes. First, an E1 activating 
enzyme forms a thiol ester bond with Ub in an ATP dependent process and then transfers Ub to an 
E2 conjugating enzyme. An E3 ubiquitin ligase then binds the E2-Ub complex and facilitates the 
formation of an isopeptide bond of Ub to the target lysine residue of the substrate. When proteins 
are modified with Ub K48 chains, the proteasome is able to recognize and subsequently degrade 
them. The 26s proteasome is made of two subunits, a 19s regulatory particle that unfolds substrates 
through recognition of poly-ubiquitin signals and a 20s core particle that carry out the proteolytic 
activity through non-specific cleavage [Nissan 2014]. Proteins need to be partially denatured in 
the 19s cap to enter the ring-like structure of the proteasome, so protein aggregates that resist 
unfolding, as seen in Huntington’s disease, can halt the UPS machinery [Chang 2015]. However, 
aggregates may also play a cyto-protective role in Huntington’s disease, as cells are isolating 
mutant htt until the proteasome can degrade it [Liou 2011]. 
Similar to ubiquitination, proteins can be post-translationally modified with a small 
ubiquitin-like modifier (SUMO) group, a 12 kDa protein, to modulate their activity, interaction, 
localization and half-life. SUMO is also attached at lysine residues and the E1 activating, E2 
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conjugating, and E3 SUMO ligases are comparable to the ubiquitin attachment complex [Gill 
2004]. There is a consensus SUMOylation site that has been identified as ΨKXE, where Ψ is a 
large nonpolar residue. As SUMO attachment is reversible, cells rely on SUMO dynamics to 
regulate key processes such as the cell cycle, stress response, and sub-cellular localization [Wei 
2006; Kerscher 2006]. There have been four different mammalian SUMO homologs identified and 
they differ slightly in structure and substrate attachment. SUMO-1 shares 18% sequence identity 
with ubiquitin and is unable to form poly-SUMO chains, as SUMO-1 lacks the consensus motif 
[Gill 2004]. However, SUMO-2 and SUMO-3 are almost identical in sequence and are known to 
form poly-SUMO chains through consensus sequence lysine attachment [Hilgarth 2004]. SUMO-
4 has only recently been characterized and is thought to be specific to the kidney, although it does 
not seem to form a conjugatable protein.  
Huntington’s and other polyglutamine diseases have an interesting connection to 
SUMOylation. Not only are the levels of SUMOylated proteins increased in these disorders, but 
SUMO is also thought to stabilize polyQ proteins and make them more soluble [Ueda 2002]. 
SUMO-1 co-localizes with htt in cells and SUMOylated htt increases neurodegeneration in 
Drosophila [Steffan 2004]. As SUMO and ubiquitin both are attached at lysine residues, 
SUMOylation may interfere with the UPS system through competition of binding sites on htt 
[Figure 1]. However, when all the htt lysine residues are mutated to be nonfunctional, 
neurodegeneration decreases [Steffan 2004]. This indicates that the increased toxicity of 
SUMOylated htt is more than just in its prevention of ubiquitin attachment.  
RNF4, A SUMO-Targeted Ubiquitin Ligase 
SUMOylated proteins are not inherently targeted for degradation, but an unusual class of 
proteins called STUbLs (SUMO-targeted ubiquitin ligases) can send them to the proteasome via 
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ubiquitin conjugation. These E3 ligases contain SUMO interacting motifs (SIMs) to specifically 
interact with SUMOylated substrates and a RING domain that dimerizes to recruit Ubiquitin E2 
conjugating enzymes [Rojas-Fernandez 2014]. As most STUbLs contain multiple SIMs, they 
interact preferentially with substrates that have multiple SUMOylated residues [Sriramachandran 
2014]. The most well-characterized human STUbL is RNF4 [Figure 2]. RING finger protein 4 
(RNF4) contains four tandem SIMs on its N-terminal domain and C-terminal RING domain 
[Poulsen 2013]. RNF4 is localized to the nucleus and contains a N-terminal bipartite NLS [Kaiser 
2003]. Known functions of RNF4 include targeting promyelocytic leukemia protein (PML) 
nuclear bodies, the kinetochore protein CENP-1, and hypoxia-inducible factors (HIFs) to the 
proteasome [Sriramachandran 2014]. STUbLs differ in size and structure between species, but 
remarkably RNF4 can functionally rescue budding yeast and fission yeast strains that lack STUbLs 
[Cook 2009].  
 
Figure 2. Structural schematic of RING finger protein 4 (RNF4) constructs. (A) Full length 
(FL) RNF4 contains a N-terminal nuclear localization signal (NLS), four SUMO-Interacting 
Motifs (SIMs), and a C-terminal RING domain that dimerizes to recruit an E2 conjugating enzyme 
to ubiquitinylate SUMOylated substrates. (B, C) ΔRING and ΔSIM mutants of RNF4, 
respectively, are used later in this study to assess what domains of RNF4 are necessary for htt 
interaction.  
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While STUbLs have mainly been implicated in the DNA damage response and genome 
maintenance, the potential to target SUMOylated proteins to the proteasome has far reaching 
applications in polyglutamine diseases. As the field has shown that htt can become enriched in the 
nucleus, can become SUMOylated, and is a target of the UPS machinery, STUbLs may represent 
a potent mechanism for nuclear htt degradation [Guo 2015]. Previous data from our lab have 
implicated the importance of the yeast STUbLs SLX5 and SLX8 in modulating htt toxicity and 
aggregate formation [Figure 3]. In yeast strains transfected with human 103Q htt, SLX5 and SLX8 
are necessary for cell survival, indicating that these STUbLs play a key role in reducing cellular 
stress [Figure 3a]. Similarly, an extra copy of SLX5 alters the morphology of aggregates, as htt 
appears more diffuse in the cell instead of forming inclusion bodies [Figure 3b]. In order to 
investigate the relationship between SLX5 and htt, yeast two hybrid assays were previously 
performed in the Kerscher lab. Two hybrid assays are a potent tool to investigate the interaction 
of two proteins.  Briefly, yeast cells are co-transformed with a Gal4-AD (activation domain) fusion 
of a protein X and a Gal4-BD (DNA binding domain) fusion of a protein Y – interaction of both 
fusion proteins result in reporter gene activation. Surprisingly, we determined that Gal4-AD 
fusions of htt activate reporter gene transcription in the absence of a Gal4-BD fusion protein 
[Figure 4, red arrows]. This significant auto-activation of htt was reduced in the presence of a 
STUbL Gal4-BD fusion of SLX5 and RNF4 [Figure 4, blue arrows]. These effects provide 
additional evidence that htt may function as a transcriptional regulator through its polyQ region 
and that STUbLs are involved in its regulation.  
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Figure 3. The yeast STUbLs SLX5 and SLX8 are necessary for modulating 103Q htt toxicity 
and aggregate formation.	(A) Yeast strains that contain deletions of SLX5 or SLX8 are still viable 
with 25Q htt but do not survive in the presence of 103Q htt in a serial dilution spotting assay. (B) 
WT yeast cells expressing 103Q htt with either a plasmid that contains an extra copy of SLX5 or 
empty vector (EV). Diffuse staining cells and cells with aggregates were counted and show that 
SLX5 reduces htt aggregates. These experiments were performed by Gloria Driessnack-Sclar in 
the Kerscher lab. 
*Unpublished data by Gloria  
Driessnack-Sclar 
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Figure 4. Huntingtin transcriptional auto-activation is reduced with the addition of SLX5 
BD and RNF4 BD. Yeast two hybrid assays show that SLX5 and RNF4 decrease htt-dependent 
HIS3 and lac-Z reporter gene activation. Red arrows show 55Q htt induced reporter gene activation 
while blue arrows indicate the reduction of htt auto-activation by SLX5 or RNF4. Interaction of 
Smt3 (yeast homolog of SUMO) and SLX5 represent a positive control. These data were 
performed by Nagesh Pasupala in the Kerscher lab. 
 
Specific Aims 
While yeast is a useful and established model organism for studying specific effects of 
polyglutamine disorders, conditions such as Huntington’s disease rely on the complex dynamics 
of mammalian cell feedback that cannot always be replicated in non-mammalian models. 
Therefore, we generated mammalian two hybrid constructs to elucidate the relationship between 
htt and the human STUbL, RNF4. We hypothesized that there would be significant auto-activation 
in the mammalian cell model, as seen in the yeast two hybrid assay, and that RNF4 could prevent 
htt from interacting with DNA.  
*Unpublished  
data by Nagesh  
Pasupala 
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The specific aims of this thesis are as follows: 
1. To determine whether htt inappropriately activates reporter gene transcription. We 
will use two hybrid constructs to assess whether htt auto-activates reporter gene 
transcription in a variety of mammalian cell lines.  
2. To verify the previously established inhibitory relationship between htt and RNF4 in 
a mammalian two hybrid assay. We will assess whether the presence of RNF4 prevents 
htt from inappropriately activating transcription of a reporter gene in a variety of 
mammalian cell lines.  
3. To assess the strength of RNF4-mediated inhibition of htt transcriptional activity. The 
amount of transcriptional reduction will be analyzed for differential concentrations of 
RNF4 in an attempt to characterize its potency.  
4. To identify what domains of RNF4 are necessary for htt transcriptional repression. 
RNF4 truncations will be tested for their levels of htt inhibition.   
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MATERIALS AND METHODS 
Cell Culture  
Thawed tissue culture cells were warmed at 37° C for several minutes before being added 
to a conical tube containing 5 ml of the appropriate media (detailed below). Cells were spun for 2 
minutes at 1000 rpm and the media was aspirated off, leaving the cell pellet intact. The cells were 
resuspended in 1 ml media and added to a new flask containing 20 ml media. The media was 
changed 48 hours after starting a new cell line.  
HeLa, PC3, PNT2, and LNCaP cells were grown in RPMI media with 10% heat inactivated 
FBS (ThermoFisher Scientific #10438018) and 1% antifungal/antibiotic (anti/anti) (ThermoFisher 
Scientific #15240062). HEK 293 cells were grown in DMEM media with 10% heat inactivated 
FBS and 1% anti-anti. PC12 cells were grown in RPMI media with 10% heat inactivated FBS, 
10% horse serum, and 1% anti/anti. 
All cell lines were grown at 37° C and 5% CO2, in a humidified incubator.  Cells were split 
when ~80% confluent and counted using a hemocytometer. Cells at the appropriate confluency 
were washed using 5 ml dPBS (ThermoFisher Scientific #14190136) and detached with 0.25% 
trypsin (ThermoFisher Scientific 25200072). Once the cells were detached, they were spun for 2 
minutes at 1000 rpm and the media was aspirated off. Cell pellets were then resuspended in 5 ml 
of the appropriate media and 1 ml was transferred to a new flask with fresh media. To freeze cell 
samples, cell pellets was resuspended in 1ml media + 10% DMSO, placed inside a styrofoam 
container, and stored at -80° C.  
Mammalian Cell Transfection 
Cell were grown to 80% confluency and counted using a hemocytometer. For 96-well 
plates (Millipore Sigma CLS3799), 5,000 cells in 100 ul media were added to each well while 6-
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well plates (Fisher Scientific 07-200-83) received 300,000 cells in 1 ml media in each well. Cells 
were incubated for 24 hours until 80% confluent.  
Earlier stages of the project used Lipofectamine 2000 Reagent while later Lipofectamine 
3000 Reagent was used to maximize transfection efficiency and reduce toxicity. In both protocols, 
100 ng or 2500 ng of DNA was added to 96-well plate or 6-well plate wells, respectively. For 96-
well plate transfections, 0.3 ul of Lipofectamine 3000 reagent and 0.2 ul of p3000 reagent were 
added to each well. 6-well plate experiments received 3.75 ul of Lipofectamine 3000 and 5 ul of 
p3000 reagent in each well. Earlier experiments used 0.5 ul and 5ul of Lipofectamine 2000 reagent 
in 96-well plate and 6-well plate wells, respectively. First, Lipofectamine 2000 or 3000 reagent 
were diluted in Opti-MEM (ThermoFisher #3195062) and incubated for 10 minutes. The diluted 
Lipofectamine mixture was then added to the respective DNA vectors diluted in Opti-MEM and 
p3000 reagent, when appropriate. After a 20-minute incubation, samples were transfected in 
triplicate for 96-well plate experiments and once for 6-well plate experiments.  
The media was replaced five hours after transfection for 96-well plate transfections while 
the wells were flooded halfway two hours after transfection for 6-well plate transfections and 
subsequently replaced 24 hours later. For Secreted Alkaline Phosphatase (SEAP) Assays, tissue 
culture supernatants were collected 48 hours after transfection. Cell extracts were harvested 48 
hours after transfection for western blot analysis.  
Secreted Alkaline Phosphatase (SEAP) Assay 
 The Great EscAPe Chemiluminescence kit (Clontech #631737) was used to detect SEAP 
levels. Twenty-five ul of culture media were obtained and spun for 1 minute at 12,000 rpm to 
remove cells. The supernatant was transferred to black 96-well plates with clear, flat well bottoms 
(Corning #353219). Seventy-five ul of 1x dilution buffer was added to each well and the plate was 
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incubated for 30 minutes at 65° C. The plate was cooled on ice for 3 minutes then equilibrated to 
room temperature. One hundred ul of SEAP substrate solution was added to each well and the 
samples were incubated for 30 minutes at room temperature. Chemiluminescent signals were 
visualized and analyzed using a Li-COR C-Digit Blot Scanner and also autoradiography film. 
Cell Extract Preparation 
 Forty-eight hours after transfection, cells in 6-well plates were washed with dPBS. 300 ul 
of 1X Cell Lysis Buffer (1X CLB) (Cell Signaling #9803) was added to each well and the samples 
incubated on ice for 10 minutes with frequent shaking. Cells were scraped to remove any residual 
adherent cells and the samples were sonicated for 10 seconds at 10% amplitude. The extracts were 
then clarified for 8 minutes at 15,000 rpm and the supernatant was collected for further analysis.   
Western Blot Analysis 
Samples were run on a pre-cast NuPAGE 4-12% Bis-Tris Protein Gel (ThermoFisher 
Scientific NP0321BOX) for 50 minutes at 200 V. Proteins were then transferred to either a 
polyvinylidene fluoride (PVDF) (ThermoFisher Scientific LC2002) or nitrocellulose membrane 
(ThermoFisher Scientific #77012) for 25 minutes at 19V. The membrane was blocked in 1xTBS 
with 4% nonfat dry milk for 1 hours. The respective primary antibody in 1xTBS with 4% nonfat 
dry milk was incubated with the membrane overnight rocking at 4° C. The membrane was washed 
three times in 1x TBS containing 0.1% Tween 20 (TBS-T) for 10 minutes before adding the 
respective HRP-linked secondary antibody in 1xTBS containing 4% nonfat dry milk. The 
membrane incubated in the secondary antibody for at least 1 hour. Finally, the membrane was 
washed for at least 30 minutes 1x TBS-T before developing with ECL substrate (Millipore Sigma 
WBKLS0500). Data shown in this study used a 1:1,000 β-Tubulin Rabbit Polyclonal antibody 
with a 1:15,000 secondary antibody (Li-Cor 926-42211]. 
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Plasmids used in this study 
 
Figure 5. Mammalian two hybrid binding domain (pM), activation domain (pVP16), and 
reporter gene (pG5SEAP) constructs. RNF4 variants were inserted into the pM-BD vector. 25Q 
and 55Q htt were inserted into the pVP16-AD vector. The pG5SEAP reporter gene vector allowed 
for secreted alkaline phosphatase production when activated.  
 
The pVP16 Activation Domain (AD) htt constructs were designed in the Kerscher lab and 
synthesized by Genewiz (South Plainville, NJ). Different truncations of RNF4 were ligated in the 
pM Binding Domain (BD) plasmid, as detailed below. The pG5SEAP vector allowed for SEAP 
transcription when the Gal4 BD was activated, which was subsequently quantified as detailed 
above [Figure 5]. Colors in the RNF4-BD vectors correlate to the schematic in Figure 2.  
pVP16-htt25Q: 
MGPKKKRKVAPPTDVSLGDELHLDGEDVAMAHADALDDFDLDMLGDGDSPGPGFTPH
DSAPYGALDMADFEFEQMFTDALGIDEYGGEFMATLEKLMKAFESLKSFQQQQQQQQ
QQQQQQQQQQQQQQQQQPPPPPPPPPPPQLPQPPPQAQPLLPQPQPPPPPPPPPPGPAVAE
EPLHRGSVDASAEASR* 
 
pVP16-htt55Q-AD: 
MGPKKKRKVAPPTDVSLGDELHLDGEDVAMAHADALDDFDLDMLGDGDSPGPGFTPH
DSAPYGALDMADFEFEQMFTDALGIDEYGGEFMATLEKLMKAFESLKSFQQQQQQQQ
QQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQPPPPPPPPP
PPQLPQPPPQAQPLLPQPQPPPPPPPPPPGPAVAEEPLHRGSVDASAEASR* 
 
pM-FL RNF4-BD 
MSTRKRRGGAINSRQAQKRTREATSTPEISLEAEPIELVETAGDEIVDLTCESLEPVVVDL
THNDSVVIVDERRRPRRNARRLPQDHADSCVVSSDDEELSRDRDVYVTTHTPRNARDE
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GATGLRPSGTVSCPICMDGYSEIVQNGRLIVSTECGHVFCSQCLRDSLKNANTCPTCRKK
INHKRYHPIYI* 
 
pM-ΔR RNF4-BD 
MSTRKRRGGAINSRQAQKRTREATSTPEISLEAEPIELVETAGDEIVDLTCESLEPVVVDL
THNDSVVIVDERRRPRRNARRLPQDHADSCVVSSDDEELSRDRDVYVTTHTPRNARDE
GATGLRPSGTVS* 
 
pM-ΔS RNF4-BD 
MSTRKRRGGAINSRQAQKRTREATSTPEISLEAEPDERRRPRRNARRLPQDHADSCVVSS
DDEELSRDRDVYVTTHTPRNARDEGATGLRPSGTVSCPICMDGYSEIVQNGRLIVSTECG
HVFCSQCLRDSLKNANTCPTCRKKINHKRYHPIYI* 
 
 To obtain pM-RNF4-BD, primers were designed for the EcoR1 and HindIII sites on the 
pM BD plasmid. Full length RNF4 (BOK 1282) was purified and amplified using Q5 Hot Start 
High Fidelity PCR. After verification of the PCR product, RNF4 was cloned and added to 
competent cells. The cells were then heat-shocked for 45 seconds at 42° C and incubated at for 1 
hours at 37° C with shaking. Cells were plated on ampicillin LB plates overnight and the vector 
was subsequently purified. The pM BD vector and the RNF4 vector were then digested using 
EcoR1 and HindIII for 1 hour at 37° C and then the pM BD vector was incubated with calf-intestine 
phosphatase (CIP) for 30 minutes at 37° C. Both digested vectors were separated on a 1% agarose 
gel and the correctly digested fragments were extracted from the gel for purification. RNF4 and 
pM-BD were then ligated together using blunt TA ligase (New England BioLabs M0367S) and 
then transformed into bacteria. Cells were plated on ampicillin LB plates overnight and the ligated 
pM-RNF4-BD vector was subsequently purified. Diagnostic digests and sequencing were used to 
verify the correct construct. 
 To obtain pM-ΔR RNF4-BD and pM-ΔS RNF4-BD, primers were designed to remove the 
respective domains. The RING Only primers removed residues 106 to 210 of full length RNF4 
and the SIM Only primers removed residues 394 to 570. After size verification on an agarose gel, 
a Kinase, Ligase, and Dpnl (KLD) (New England BioLabs M0554S) enzyme mixture was used to 
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ligated the pM-RNF4-BD vector back together. The ligated vectors were then added to competent 
cells and heat shock for 30 seconds at 42° C. The cells were then incubated for 1 hour at 37° C 
with shaking and plated on ampicillin LB plates overnight. The purified vectors were then verified 
with diagnostic digests and sequencing. 
Statistical Analysis 
Student t-tests were used to analyze statistical significance of SEAP transcriptional levels. 
A significance level of 0.05 was used to establish significance.  
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RESULTS 
I. A Mammalian Two Hybrid Assay to investigate the interaction of htt with RNF4 
In this study, we investigated the interaction of htt with the human STUbL protein RNF4 
in a mammalian two hybrid system. As described earlier, two hybrid assays are an essential tool 
to establish if two proteins interact. In the mammalian assay, cells are transfected with three 
constructs- a Gal4 binding domain (BD) fusion of a protein X, a Gal4 activation domain (AD) 
fusion of a protein Y, and a reporter gene vector. The Clontech two hybrid system contains a BD 
construct called pM, an AD construct called pVP16, and the reporter gene is secreted alkaline 
phosphatase (SEAP) in a construct called pG5SEAP.  
In order to assess the interaction of RNF4 and htt, various combinations of AD and BD 
plasmids were transfected into mammalian cells containing equal amounts of the reporter gene. 
Gal4 AD htt constructs were synthesized to represent N-terminal htt. 25Q htt AD represents the 
soluble, non-toxic version of htt while 55Q htt AD represents an aggregation-prone form of htt 
with moderate toxicity. Cell counts of 25Q and 55Q htt transfected cells were determined to be 
non-significantly different (data not shown). The positive control condition expressed a fused pM-
pVP16 construct that constitutively activated SEAP transcription [Figure 6a]. The negative control 
condition expressed unfused pM and pVP16 vectors to indicate the level of experimental 
background of reporter gene activation [Figure 6b]. To measure htt auto-activation, 25Q and 55Q 
htt AD vectors were co-transfected with EV BD [Figure 6c and 6d]. RNF4’s inhibitory effect was 
assessed by co-transfecting 25Q and 55Q htt AD vectors with RNF4 BD [Figure 6e and 6f]. All 
transfected cells also expressed the pG5SEAP plasmid, which allowed for quantification of 
transcriptional activation. Based on the previous yeast two hybrid results in Figure 4, 55Q htt was 
expected to induce more SEAP transcription than 25Q htt, as 55Q’s polyQ tract is modeled after a 
pathogenic htt fragment.  
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Figure 6. Mammalian two hybrid constructs. (A) The fused pM-pVP16 construct was a positive 
control construct that was used to normalize transcriptional levels. (B) The unfused pM and pVP16 
constructs indicated experimental background and acted as a negative control. (C, D) Reporter 
gene auto-activation by 25Q and 55Q htt, respectively, was assessed by transfection of pM-EV and 
pVP16-htt. (E, F) pM-RNF4 was cotransfected with 25Q and 55Q htt, respectively, to measure 
RNF4’s inhibitory function.  
 
II. Htt induces reporter gene auto-activation in five diverse mammalian cell lines 
To identify the optimal condition for our mammalian two hybrid htt assays, we tested six 
different cell lines. The first attempt of the mammalian two hybrid assay was carried out in HeLa 
cells, a cervical adenocarcinoma line, but due to endogenous placental alkaline phosphatase 
production, results obtained were inconsistent, prompting us to halt experiments with this cell line. 
Next, we used three different prostate cell lines to assess the relationship between htt and RNF4: 
PC3 cells which are derived from a prostate adenocarcinoma, LNCaP cells which are derived from 
a prostate carcinoma, and PNT2 cells which are derived from a normal prostate epithelium. Human 
embryonic kidney (HEK293) cells were also used for mammalian two hybrid analysis. Most 
importantly, PC12 cells, a neuron-like cell line derived from a rat pheochromocytoma, were also 
subjected to two hybrid analysis. 
Huntington’s causes the deterioration of neuronal cells which may be partially due to the 
abnormal transcriptional activity associated with htt. Interestingly, as detailed below, our results 
suggest that this htt-dependent transcriptional activity can be observed in all cell lines tested [Table 
1]. However, due to their neuronal origin, results from the PC12 cell two hybrid should be 
emphasized and viewed as the most physiologically relevant model of Huntington’s disease. 
Unexpectedly, 25Q htt induced more SEAP transcription than 55Q htt in most cell lines. The 
notable exception to this trend was observed in neuronally derived PC12 cells; in these cells, 55Q 
htt exhibited statistically significantly greater transcriptional activation than 25Q htt (p=0.003). 
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Cell Line Origin EV-AD 25Q htt-AD 55Q htt-AD 
PC3 
Prostate 
adenocarcinoma 
0% 86% 75% 
LNCaP Prostate carcinoma 0% 98% 84% 
HEK293 Embryonic kidney 0% 83% 68% 
PNT2 Prostate epithelium 13% 88% 67% 
PC12 
Rat 
pheochromocytoma 
26% 88% 100% 
Table 1. Htt auto-activates reporter gene transcription in a host of cell lines. Mammalian two 
hybrid assays of EV-BD with either EV-AD, 25Q htt- AD, or 55Q htt- AD. Reporter gene auto-
activation was measured by 25Q htt-AD and 55Q htt-AD while the experimental background was 
measured by EV-AD. All values are normalized to the positive control construct’s SEAP 
expression in that cell line (fused pM-pVP16). 
 
III. RNF4 reduces the transcriptional activity of polyQ constructs 
A. Presence of RNF4 BD reduced htt auto-activation in five mammalian cell lines 
As htt’s transcriptional auto-activation may present a major problem for 
Huntington’s patients, this study investigates a RNF4-mediated mechanism to modulate it. 
Mammalian two hybrid analysis of PC3, LNCaP, HEK293, PNT2, and PC12 cells displayed a 
significant decrease in the transcriptional activation of 25Q and 55Q htt with the addition of RNF4 
BD [Figure 7A and 7B]. In contrast, positive control (fused pM-pVP16) activation, was not 
reduced by RNF4-BD [Supplemental Figure 1]. The strength of RNF4’s inhibitory effect was 
dependent on the specific cellular environment, but ranged from 30-60% reduction [Table 2]. 
While the amount of transcriptional reduction varied between cell lines, the overall reductions 
were statistically significant, indicating that RNF4’s inhibitory effect is consistent and replicable. 
In all cell lines, 55Q htt displayed greater transcriptional reduction (%), suggesting that 55Q htt is 
more amenable to RNF4’s activity [Figure 7C].  
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B)
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C) 
 
Figure 7. RNF4 reduces the transcriptional activation of htt. Mammalian two hybrid analysis 
of PC3, LNCaP, HEK 293, PNT2, and PC12 cells [n=3]. (A, B) The conditions described in Figure 
6 were tested and normalized to the positive control. Standard deviation is shown by error bars.  
* p<0.05, ** p<0.01, *** p<0.001. (C) Percent reduction in average SEAP luminescence by RNF4 
was plotted. Reduction in 25Q and 55Q htt auto-activation by RNF4 is shown in yellow and red, 
respectively.  
 
AD 25Q 25Q % 55Q 55Q % 
BD EV RNF4 Reduction EV RNF4 Reduction 
PC3 86 37 57 75 30 61 
LNCaP 98 57 42 84 27 68 
HEK293 83 36 56 69 23 67 
PNT2 88 62 30 67 37 44 
PC12 88 60 31 100 58 43 
 
Table 2. Transcriptional reduction of htt auto-activation with RNF4-BD.  Difference in 
relative htt transcriptional activity without and with RNF4 was calculated from the average SEAP 
luminescence. Values displayed in this table are graphed in Figure 7C.  
 
B. Levels of RNF4 BD are correlated to the reduction in htt auto-activation 
To test whether RNF4’s inhibitory effect was additive, the amount of RNF4 BD 
was changed while the concentrations of 55Q htt AD and pG5SEAP were held constant in PC3 
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cells. As 50ng of full length (FL) RNF4 is typically transfected into cells, varying multiples of 50 
ng of RNF4 were tested. A general inverse relationship was observed, as increasing FL RNF4 
resulted in less transcriptional activity by 55Q htt [Figure 8A]. RNF4’s inhibitory function did not 
linearly correlate with its concentration but more experimentation is necessary to verify the exact 
relationship between RNF4 concentration and reduction in htt reporter gene activation [Figure 8B]. 
This dose-dependent relationship could be due to decreasing relative substrate concentrations, as 
the amount of htt is constant while RNF4 is increasing. One potential possibility is that 55Q htt 
fails to interact with the reporter plasmid as increasing amounts of RNF4 also increase the 
likelihood that htt is ubiquitinylated and as other factors are recruited that aid in htt’s removal (see 
discussion).  
 
A)  
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B) 
 
Figure 8. Increasing concentrations of RNF4 lead to a corresponding reduction in 
Huntingtin’s transcriptional activity. Mammalian two hybrid assay of PC3 cells with varying 
concentrations of full length (FL) RFN4 [n=3]. (A) Positive control, negative control, and 
untransfected conditions were conducted as described earlier and all conditions were normalized 
to the positive control. 55Q htt- AD was then co-transfected with either 0, 25, 50, 100, or 200 ng 
of RNF4- BD and the relative SEAP luminescence was plotted. Standard deviation is shown by 
error bars. (B) The average reduction in 55Q htt auto-activation was plotted as a function of RNF4 
concentration.  
 
C. An extra copy of non-BD mCherry RNF4 has little to no effect on htt auto-activation 
In order to verify RNF4’s inhibitory effect, mCherry RNF4 without a Gal4 BD 
domain (non-BD) was transfected into PC3 cells along with 55Q htt and pG5SEAP. A reduction 
in htt-mediated transcriptional activity was observed, although the effect was not statistically 
significant [Figure 9]. RNF4 is localized to the nucleus, although it primarily is associated with 
double-stranded DNA breaks [Sriramachandran 2014]. Overexpressing non-BD RNF4 increases 
the likelihood of RNF4 preventing htt from activating transcription, but RNF4 is not guaranteed 
to be recruited to that specific transcriptional site of the Gal4 UAS enhancer. The transcriptional 
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reduction observed with non-BD RNF4 expression is worth noting, but further experimentation is 
required to verify this effect and establish potential statistical significance. 
 
Figure 9. Addition of non-BD RNF4 results in little transcriptional reduction. Mammalian 
two hybrid analysis of PC3 cells [n=3]. Positive control, negative control, and untransfected 
conditions were conducted as described earlier and all conditions were normalized to the positive 
control. 55Q htt- AD was either transfected in alone or with non-BD mCherry RNF4. Standard 
deviation is shown by error bars. 
 
IV. RNF4 truncations lead to enhanced reduction in Huntingtin’s transcriptional Activation 
A. RING and SIM deletions of RNF4 enhance reduction in 25Q and 55Q htt auto-activation 
To determine the domains of RNF4 that are responsible for its inhibitory function, 
two RNF4 truncation mutants were generated [Figure 2]. The ΔR mutant lacked the catalytic RING 
domain while the ΔS mutant had the SUMO-Interacting Motifs (SIMs) of RNF4 removed. It was 
hypothesized that ΔR RNF4, which retains the SIMs and lacks the RING domain, would inhibit 
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htt’s transcriptional activity less efficiently, as it only contains the recognition sites of RNF4. 
Similarly, ΔS RNF4 was hypothesized to display a reduced ability similar to FL RNF4, as the 
RNF4 BD would only lack recognition sites and the RING domain could potentially still dimerize 
with a native, functional full-length (FL) RNF4 to still carry out the ubiquitinylation function of 
FL RNF4. Surprisingly, both truncation mutants displayed enhanced ability to reduce 25Q and 
55Q htt’s auto-activation compared to FL RNF4 [Figure 10]. The ΔS mutant displayed the most 
robust reduction (76 – 94%) followed by the ΔR mutant (35 – 62%) and the FL RNF4 (18 – 26%). 
This mammalian two hybrid experiment was repeated five times to verify this effect and two 
experiments are shown to indicate reproducibility. Cells were grown and transfected in 6-well 
plates to assess protein levels, and determined to be non-significant between FL, ΔR, and ΔS 
[Supplemental Figure 2].  
A) 
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B) 
 
 
Figure 10. RNF4 truncations lead to enhanced reduction in Huntingtin’s transcriptional 
activation. Mammalian two hybrid analysis of PC3 cells [n=3]. Positive control, negative control, 
and untransfected conditions were conducted as described earlier and all conditions were 
normalized to the positive control. 25Q htt- AD (A) or 55Q htt (B) were co-transfected with either 
EV-BD, full length RNF4 (FL)-BD, a RING deletion mutant of RNF4 (ΔR)-BD, or a SIM deletion 
mutant of RNF4 (ΔS)-BD. Standard deviation is shown by error bars. 
 
B. Htt auto-activation is consistently reduced by RNF4 truncations. 
Multiple RNF4 truncation experiments allowed us to statistically evaluate the reduction of 
htt-mediated SEAP transcription. Since PC3 cells were used in both attempts, the amount of auto-
activation present in 25Q htt and 55Q htt were normalized to 0% reduction. The different variants 
of RNF4 therefore had positive reductions in SEAP. We observed that the percent reduction in 
SEAP transcription was overall consistent between both experiments, notably so in the 55Q htt 
results [Tables 3 and 4]. The difference in average transcriptional reduction by RNF4 variants 
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ranged from 6 – 27% with 25Q htt and 2 – 7% with 55Q htt. This suggests that enhanced reduction 
by truncations of RNF4 is a real effect and that deleting the RING or the SIMs is possibly making 
RNF4 less specific in its interactions. If the ΔR and ΔS mutants are non-specifically interacting 
with a wider range of targets, htt could be blocked from accessing the SEAP transcription site.  
AD 25Q 25Q 25Q 25Q 
BD EV FL RNF4 ΔR RNF4 ΔS RNF4 
First 
Attempt 
0% 18% 
 
35% 76% 
Second 
Attempt 
0% 25% 62% 82% 
Difference  – 7% 27% 6% 
Table 3.  Transcriptional reduction of htt 25Q by RNF4 truncations. The SEAP luminescence 
of 25Q htt-AD with EV-BD (auto-activation) was set to 0% and the transcriptional reduction by 
RNF4 variants were calculated from the data shown in Figure 10A. 
 
 
AD 55Q 55Q 55Q 55Q 
BD EV FL RNF4 ΔR RNF4 ΔS RNF4 
First 
Attempt 
0% 19% 
 
54% 91% 
Second 
Attempt 
0% 26% 55% 94% 
Difference – 7% 2% 2% 
Table 4. Transcriptional reduction of htt 55Q by RNF4 truncations. The SEAP luminescence 
of 55Q htt-AD with EV-BD (auto-activation) was set to 0% and the transcriptional reduction by 
RNF4 variants were calculated from the data shown in Figure 10B. 
 
 The reporter gene auto-activation by htt described in this study supports recent evidence 
that htt is involved in altering transcriptional profiles. We have shown that this auto-activation can 
be significantly modulated in five mammalian cell lines transfected with RNF4. Additionally, our 
data show that SIM and RING deletions of RNF4 are more effective at reducing htt’s 
transcriptional activity, which suggests that the mechanism of reducing htt-mediated transcription 
by RNF4 is complex and may involve both inter and intra-molecular interactions. 
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DISCUSSION 
 The STUbL protein RNF4 plays pivotal genome maintenance roles in mammalian cells but 
it has only recently been implicated in Huntington’s disease [Kerscher 2016]. In this study, we set 
out to investigate RNF4’s role in managing the abnormal transcriptional activity of huntingtin. 
This research made use of mammalian two hybrid assays to investigate the transcriptional auto-
activation of htt and whether RNF4 could prevent htt from interacting with a reporter gene 
construct. We determined that the presence of RNF4 significantly reduced the transcriptional 
activation of htt in five different cell lines. Additionally, we found that RNF4 mutants lacking 
either SIMs or a RING domain retain considerable ability to repress htt-mediated transcriptional 
activity.   
 Our results implicate RNF4 in the management of the abnormal transcriptional activity of 
nuclear htt. In cells that express wildtype huntingtin, this non-expanded htt is not cleaved by 
proteases and remains cytosolic due to its nuclear export signal. Cells that express polyQ htt have 
both cytosolic and nuclear aggregates, possibly due to the presence of N-terminal htt fragments 
that lack a nuclear export signal (NES). Our two hybrid model of Huntington’s disease mimics the 
presence of N-terminal fragments in the nucleus through a pVP16-htt-AD construct which contains 
an NLS as part of the AD vector. The extensive auto-activation of 25Q and 55Q htt confirms 
previous observations that htt can interact with DNA and transcription factors, likely through its 
poly-glutamine tract. The addition of pM-RNF4-BD significantly reduces this inappropriate 
transcriptional activation and offers a tentative pathway for the removal of nuclear htt. Our current 
model of RNF4-mediated htt removal and degradation is detailed in Figure 11. In this model, N-
terminal fragments of mutated htt form and enter the nucleus after protease-mediated 
fragmentation. Next, transcription factors and other regulatory proteins interact with htt fragments 
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via glutamine-mediated interactions. These polyglutamine-mediated complexes disrupt normal 
transcriptional regulation, as transcription factors are inappropriately recruited to the site of htt-
DNA association. The exact transcriptional changes remain unknown and research into this area 
will clarify how Huntington’s disease dysregulates transcriptional programs. Htt can then be 
SUMOylated by an E3 SUMO ligase such as RanBP2 to increase htt’s solubility. As SUMOylated 
htt begins forming nuclear aggregates and interacting with DNA, RNF4 then is recruited to 
conjugate ubiquitin chains to htt. These poly-ubiquitin tags are then recognized by UFD1L, which 
has dual SUMO and ubiquitin recognition sites. NPLOC4 is also recruited via interaction with 
UFD1L. Finally, VCP/p97 mediates translocation to the proteasome and degradation of htt.  
 
Figure 11. Model of RNF4-mediated degradation of nuclear htt. PolyQ extended, toxic 
huntingtin (htt) is normally cytosolic, but can be cleaved and enter the nucleus. Htt can then induce 
transcriptional changes through glutamine-mediated interaction with regulatory proteins. Htt can 
become SUMOylated by an E3 SUMO ligase and then subsequently ubiquitinylated by RNF4. 
Finally, the ubiquitin-proteasome system (UPS) can be recruited through dual SUMO-ubiquitin 
sites and htt can be removed and degraded.  
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Although the mechanism is unclear, it seems that STUbLs such as RNF4 play a role in 
managing toxic htt aggregates. Since RNF4 is localized to the nucleus, it is likely that it helps with 
removing nuclear htt and prevents it from altering the transcriptome. Htt contains three notable 
lysine motifs in its N-terminus that have been shown to be sites for either Ub or SUMO attachment. 
While Ub conjugation would target htt to the proteasome, SUMO conjugation actually stabilizes 
htt and makes it more soluble. When SUMOylated htt accumulates in the nucleus, we are 
proposing that RNF4 and its associated UPS machinery work to relieve that nuclear stress. This 
pathway could possibly be manipulated to enhance Huntington’s outcomes. By overexpressing 
RNF4 or inhibiting the E3 SUMO ligase that SUMOylates htt, cells could potentially stabilize 
their nucleus and prevent further transcriptional changes. RNF4 would be a more ideal target than 
the E3 SUMO ligase, as RNF4 is more specific and would likely cause less harmful side effects. 
E3 SUMO ligases are also involved in managing nuclear stress, such as replication fork errors, so 
inhibiting these ligases would create new problems for cells.  
RNF4 is known to be a homodimer, as the dual RING domains recruit an E2 conjugating 
enzyme to attach ubiquitin to substrates while the SUMO Interacting Motifs (SIMs) function as a 
regulatory domain to enhance target specificity. As each cell line expresses differential levels of 
endogenous RNF4, the chance of RNF4 dimerizing to recruit the E2 enzyme and ubiquitinylate 
substrates also differs between cell lines. Therefore, the extent that RNF4 could repress htt’s 
transcriptional activity was specific to the cellular environment. Even so, the conserved nature of 
RNF4’s inhibitory effect between cell lines was striking.  
Synthesizing RNF4 mutants that lacked either their RING or SIM domain allowed for 
investigation into what domains are necessary for RNF4’s inhibitory function of htt. It was 
hypothesized that the ΔR mutant would exhibit less transcriptional reduction, as it only contains 
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the regulatory SIMs. However, it was observed that there was greater reduction in SEAP 
transcription with the ΔR mutant. One possible explanation is that the ΔR mutant nonspecifically 
interacts with SUMOylated substrates in the cell, including SUMO chains and chromatin. 
Removing the RING domain decreases RNF4’s specificity and possibly alters its structure, 
allowing the ΔR mutant to interact with a wider range of SUMOylated substrates and preventing 
htt from activating transcription. It was also hypothesized that removing RNF4’s SIM domains 
would not change its ability to reduce htt’s transcriptional activity, as the catalytic RING domain 
is still present in the ΔS mutant. However, the ΔS mutant again showed enhanced transcriptional 
reduction. We hypothesize that the ΔS mutant nonspecifically adds ubiquitin to DNA binding 
proteins, resulting in differential localization. Without the regulatory domain, the RING domain 
may interact with a greater number of targets, thereby reducing the likelihood that htt could interact 
with the Gal4-UAS enhancer on the reporter plasmid. 
As the ΔS mutant showed the best transcriptional reduction followed by the ΔR and the FL 
RNF4, it is possible that as RNF4 gains specificity, its interaction with htt is increased. The ΔR 
and ΔS mutants both may exhibit a wider range of targets, which could prevent htt from interacting 
with DNA and activating SEAP transcription. FL RNF4 is more specific to htt, as it contains both 
the catalytic RING and regulatory SIM domains and can properly fold, so FL has fewer targets 
and the chance of htt transcriptional activation is increased. Since RNF4 only adds ubiquitin to 
SUMOylated substrates, we would still expect some levels of htt-DNA interaction if htt is not 
SUMOylated at the time of the experiment. Ultimately, we do not definitively know why the RNF4 
truncations displayed enhanced reduction abilities and there are plans to investigate further into 
these relationships. Truncations are non-physiological and may be incorrectly folded or damaged. 
To account for these potential structural differences, point mutations should be made to render 
 - 35 - 
either the SIMs or the RING nonfunctional and the mammalian two hybrid assay should be 
performed with these new constructs. Nevertheless, full-length RNF4 has a potent role in reducing 
huntingtin’s transcriptional activity and its domain functionality, while unexplored, contributes to 
its inhibitory role.  
The limitations of this study necessitate further research into RNF4’s role in Huntington’s 
disease. The neuronal PC12 cell line was only obtained late into the project, so many of the 
experiments were performed in PC3 cells, which had the best transfection efficiency. Future work 
on this project should replicate results in PC12 cells to verify that the results are conserved in a 
neuronal environment. It was also found that 25Q htt induced more transcriptional auto-activation 
than 55Q htt in most cell lines, which is contrary to the known correlation between polyQ tract 
length and toxicity. However, this phenomenon has been observed in other Huntington’s studies, 
including one publication that found no statistical difference between 20Q and 86Q htt reporter 
gene auto-activation in HEK293 cells [Atanesyan 2012]. As 55Q htt is more aggregation-prone, it 
is also possible that our 55Q htt constructs aggregated in the nucleus while 25Q htt was free to 
interact with our reporter gene transcription site. Relative protein levels also need to be controlled 
for before concluding on the effectiveness of our constructs. Many attempts were made to quantify 
BD and AD protein levels but either our cell extract protocol or antibodies were not successful, so 
we could not make precise conclusions regarding the amount of BD and AD constructs the 
mammalian cells produced following transfection.  
Many applications of this project remain unexplored. Future plans include knocking out 
RNF4 with either CRISPR-Cas9 or dsRNA to observe cellular effects of htt-mediated 
transcriptional activity. First, a mammalian two hybrid assay would be performed in the RNF4 
knockout and WT cells to determine whether native amounts of RNF4 affect htt’s transcriptional 
 - 36 - 
activation. Next, the differential transcriptional profile of the knockout and the WT would be 
determined using ChIP-Seq of htt. If we can determine what genes htt is prone to interact with, we 
can better understand Huntington’s disease and how the cellular environment is altered. 
Huntington’s disease presents a significant problem in our population, as there is no current 
treatment that targets its underlying cause. This study opens up possibilities for how cells manage 
nuclear htt and resist transcriptional changes through the manipulation of the SUMO-targeted 
ubiquitin ligase, RNF4.  
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SUPPLEMENTAL FIGURES 
 
 
 
Figure S1. RNF4 does not reduce positive control SEAP transcription. Mammalian two hybrid 
analysis of PC3 cells. Positive control, negative control, and untransfected conditions were 
conducted as described earlier. In the experimental condition, the fused pM-pVP16 positive 
control vector was co-transcribed with RNF4-BD and down to have non-significantly different 
levels of transcription. 
 
 
 
 
 
 
 
 
 
Figure S2. RNF4 BD variants do not affect protein levels. 55Q htt AD was co-transfected with 
either EV-BD, full length (FL)-BD, ΔR-BD, or ΔS-BD in PC3 cells then β tubulin levels were 
measured using western blot analysis.  
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